AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Sexually Transmitted Diseases Treatment Market Size, Trends, Analysis, and Outlook By Disease (Gonorrhea, Syphilis, Herpes, Chlamydia, Hepatitis (HBV), Human Immunodeficiency Virus (HIV), Others), By Therapy (Anti-bacterial, Anti-viral, Vaccines, Anti-fungal), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Sexually Transmitted Diseases Treatment market size is poised to register 4.09% growth (CAGR) from 2024 to ... Read More
-
Point of Care HIV Testing Market Size, Trends, Analysis, and Outlook By Product (POC HIV testing equipment, POC HIV testing reagents), By End-User (Diagnostic labs, Hospitals and clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Point of Care HIV Testing market size is poised to register 3.98% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes ... Read More
-
Infectious Disease Diagnostics Market Assessment, By Product [Reagents, Kits, and Consumables, Instruments, Software], By Sample Type [Blood and Components, Urine, Other], By Setting [Laboratory Testing, Point-of-Care Testing], By Type of Testing [Molecular Tests, Serological Tests, Antigen Tests, Culture Tests, Blood Tests, Imaging Tests], By Indication [Bacterial Infections, Viral Infections, CNS Infections, Cardiovascular Infections, Fungal Infections, GI Infections, Sexually Transmitted Diseases, Other], By End-user [Diagnostic Laboratories, Academic And Medical Institutes, Hospitals, Ambulatory Clinics, Home Healthcare, Other], By Region, Opportunities and Forecast, 2017-2031F
... Antigen Tests, Culture Tests, Blood Tests, Imaging Tests], By Indication [Bacterial Infections, Viral Infections, CNS Infections, Cardiovascular Infections, Fungal Infections, GI Infections, Sexually Transmitted Diseases, Other], By End-user [Diagnostic Laboratories, Academic And Medical Institutes, Hospitals, ... Read More
-
Genital Herpes Market Assessment, By Type [Diagnosis, Treatment], By Route of Administration [Oral, Injectable, Topical], By End-user [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others], By Region, Opportunities and Forecast, 2017-2031F
... projected to witness a CAGR of 5.24% during the forecast period, 2024-2031, growing from USD 2.25 billion in 2023 to USD 3.39 billion in 2031. The global genital herpes market is shaped by various factors. ... Read More
-
Chile In Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... The emergence of COVID-19 has led to the health crisis that the world has witnessed and had an unprecedented impact on various industries and specifically the healthcare and biotechnology industries, including the in-vitro diagnostic market. ... Read More
-
Gonorrhea Diagnostic Market Size, Trends, Analysis, and Outlook By Type (Molecular Diagnostics Tests, Flow Cytometry, Diagnostic Imaging, Liposomes, Artificial Intelligence, Gel Micro-droplets, Chromatography, Differential Light Scattering, Monoclonal Antibodies), by Region, Country, Segment, and Companies, 2024-2030
... The global Gonorrhea Diagnostic market size is poised to register 8.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gonorrhea Diagnostic market ... Read More
-
Herpes Simplex Virus Treatment Market Size, Trends, Analysis, and Outlook By Type (Herpes Simplex Virus-1 (HSV-1), Herpes simplex virus-2 (HSV-2), By Drug (Acyclovir, Valacyclovir, Famciclovir, Others), By Vaccine, Simplirix, Others), By Route of Administration (Oral, Injectable, Topical), By End-User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Injectable, Topical), By End-User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Herpes Simplex Virus Treatment market size is poised to register 8.63% growth from 2024 to 2030, ... Read More
-
Cryptococcosis Therapeutics Market Size, Trends, Analysis, and Outlook By Treatment (Amphotericin B , Flucytosine , Fluconazole , Others), By Diagnosis (Bronchoscopy, X-ray, MRI, Lung Biopsy, CSF Polymerase Chain Reaction (PCR), CT scan, Others), By End-User (Clinic, Hospital, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... (Clinic, Hospital, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Cryptococcosis Therapeutics market size is poised to register 4.8% growth from 2024 to 2030, ... Read More
-
Herpes Infection Treatment Market Size, Trends, Analysis, and Outlook By Product (Therapeutics, Vaccine), By Type (Herpes Simplex, Herpes Zoster), By Drug (Acyclovir, Valacyclovir, Famciclovir, Others), By Route of Administration (Oral, Topical, Injection), By Herpes Vaccine, Herpes Simplex, Herpes Zoster), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Herpes Simplex, Herpes Zoster), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Herpes Infection Treatment market size is poised to register 7.24% growth from 2024 ... Read More
-
Global Sexually Transmitted Disease (STD) Diagnosis Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Sexually Transmitted Disease (STD) Diagnosis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antiviral Drugs market size is poised to register 4.55% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028
... The point of care diagnostics market is epected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion at a CAGR of 9.4% during the forecast period (2023–2028).The gobal rising burden of ... Read More
-
Point of Care Infectious Disease Testing Market Size, Trends, Analysis, and Outlook By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
... HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030 The global ... Read More
-
Self-testing Market Size, Trends, Analysis, and Outlook By Product (Kits, Devices, Strips), By Sample Type (Blood, Urine, Stool, Others), By Application (Blood Pressure Test, Diabetes and Glucose Tests, Cholesterol and Triglycerides Tests, Pregnancy Test, STD /STI Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others), By Distribution Channel (Online, Offline), By Usage (Disposable, Reusable), by Region, Country, Segment, and Companies, 2024-2030
... /STI Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others), By Distribution Channel (Online, Offline), By Usage (Disposable, Reusable), by Region, Country, Segment, and Companies, ... Read More
-
Infectious Disease Molecular Diagnostics Market Size, Trends, Analysis, and Outlook By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample ... Read More
-
The 2025-2030 World Outlook for Herpes Simplex Virus Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Anal Fistula Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Syphilis Immunoassays
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for HIV Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Herpes Marker Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Herpes Simplex Virus Infections
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for HIV-AIDS Confirmatory Tests
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for HIV-AIDS Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Viral Infections
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for STD Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
